Log In
Print
BCIQ
Print
Print this Print this
 

Viaskin Peanut (DBV-712)

  Manage Alerts
Collapse Summary General Information
Company DBV Technologies
DescriptionPeanut proteins epicutaneously delivered by Viaskin patch technology
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationAllergy
Indication DetailsTreat peanut allergy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today